Episode
Episode 72: Impact of Donor-Specific Antibodies on Longitudinal Lung Function and BLAD
- Podcast
- JHLT: The Podcast
- Published
- Nov 5, 2025
- Duration seconds
- 1194
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/jhlt-the-podcast-3498579/episodes/episode-72-impact-of-donor-specific-antibodies-on-longitudinal-lung-function-and-blad/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/jhlt-the-podcast-3498579/episode-72-impact-of-donor-specific-antibodies-on-longitudinal-lung-function-and-blad.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, " Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction ." They are joined by the first author, Muhtadi Alnababteh, MD , Assistant Professor at the University of Maryland and Staff Clinician at the National Institutes of Health, and senior author Michael Keller, MD , of the Pulmonary and Critical Care division at the University of Maryland. The discussion explores: Common characteristics of patients who developed donor-specific antibodies (DSA) Differences in outcomes depending on when DSA developed Associations between the development of DSA and antibody-mediated rejection, and related time frames For the latest studies from JHLT , visit www.jhltonline.org/current , or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt . Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org .